Sana Biotechnology Income Statement (2020-2026) | SANA

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
182.91M184.93M186.63M188.43M189.90M191.02M191.41M196.88M197.06M197.86M221.29M222.21M223.11M223.92M225.46M230.51M262.26M266.73M269.82M299.36M
Operating items
Research & Development (Quarter)
53.24M108.50M72.69M72.54M76.73M63.92M67.17M73.04M65.61M7.00M56.45M60.87M53.21M1.90M37.19M29.76M30.11M34.92M28.72M30.73M
Selling, General & Administrative (Quarter)
13.43M12.68M14.43M18.29M15.51M23.32M16.77M16.57M19.18M20.78M16.27M16.44M14.05M17.28M11.48M10.34M10.29M12.19M11.46M10.78M
Other Operating Expenses (Quarter)
16.75M-9.90M-55.44M-17.93M-6.06M-249.44M0.12M26.68M-82.61M-209.99M-68.66M-72.02M-64.27M-16.57M1.96M-37.86M-38.34M-44.33M8.43M23.91M
Operating Expenses (Quarter)
83.43M111.28M31.68M72.90M86.19M-162.20M84.05M116.29M2.18M-182.21M4.06M5.29M2.99M2.60M50.63M2.24M2.05M2.78M48.61M65.42M
Operating Income (Quarter)
-83.43M-111.28M-31.68M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.97M-43.52M-61.20M-48.61M-65.42M
EBIT (Quarter)
-83.43M-111.28M-31.68M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.97M-43.52M-61.20M-48.61M-65.42M
Non-operating items
Interest & Investment Income (Quarter)
-0.10M-1.28M-3.81M-1.18M-0.07M2.09M2.19M1.27M0.66M0.14M0.04M-0.00M0.07M-0.04M-0.01M0.02M0.01M-0.03M-0.06M
Other Non Operating Income (Quarter)
0.01M0.28M-0.10M-0.20M-0.11M-0.27M-0.05M-0.08M0.30M-0.22M0.21M-4.12M-0.74M0.14M0.25M0.60M0.36M1.10M0.45M0.66M
Non Operating Income (Quarter)
0.16M0.27M0.34M0.64M1.17M1.61M1.98M2.37M2.86M2.73M3.03M3.20M2.58M1.66M0.99M0.58M1.00M1.28M0.95M1.13M
Net income details
EBT (Quarter)
-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M-176.08M
Profit After Tax (Quarter)
-83.26M-110.62M-31.45M-72.47M-85.12M-83.40M-82.12M-114.00M1.65M-88.12M-107.47M-50.29M-59.92M-49.07M-49.40M-93.80M-42.15M-58.83M-47.24M-63.70M
Income from Continuing Operations (Quarter)
-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M-176.08M
Consolidated Net Income (Quarter)
-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M-176.08M
Income towards Parent Company (Quarter)
-254.38M-269.19M-215.55M-142.88M-241.01M-83.41M-188.49M-351.07M-209.07M-493.14M-196.66M-132.38M-238.12M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M-176.08M
Net Income towards Common Stockholders (Quarter)
-254.38M-269.19M-215.55M-142.88M-85.12M-83.41M-188.49M-351.07M0.98M-493.14M-196.66M-132.38M-59.92M-52.38M-217.03M-225.25M-86.08M-61.19M-162.42M-176.08M
Additional items
EPS (Basic) (Quarter)
-1.40-1.62-1.16-0.76-0.45-0.44-0.99-1.820.00-2.53-0.91-0.56-0.25-0.23-0.91-0.94-0.33-0.24-0.59-0.60
EPS (Diluted) (Quarter)
-1.40-1.62-1.16-0.76-0.45-0.44-0.99-1.820.00-2.53-0.91-0.56-0.25-0.23-0.91-0.94-0.33-0.24-0.59-0.60
Shares Outstanding (Quarter)
181.83M166.43M185.96M187.63M189.30M188.34M191.23M192.54M196.98M194.54M217.29M234.44M235.41M230.89M237.58M238.41M260.49M253.23M276.86M295.67M
Shares Outstanding (Diluted) (Quarter)
181.83M166.43M185.96M187.63M189.30M188.34M191.23M192.54M200.47M194.54M217.29M234.44M235.41M230.89M237.58M238.41M260.49M253.23M276.86M295.67M
EBITDA (Quarter)
-83.43M-111.28M-31.68M-72.90M-86.19M-81.79M-84.05M-116.29M-2.18M-90.62M-110.72M-49.37M-61.76M-50.87M-50.63M-94.97M-43.52M-61.20M-48.61M-65.42M
Interest Expenses (Quarter)
170.86M156.62M180.06M68.80M154.76M3.71M106.62M236.06M207.55M402.66M85.98M83.00M176.43M1.48M166.39M130.28M42.59M0.00M113.77M110.60M